Myshkin Ingawale: A blood test without bleeding

29 03 2012

Anemia is a major — and completely preventable — cause of deaths in childbirth in many places around the world, but the standard test is invasive and slow. In this witty and inspiring talk, TED Fellow Myshkin Ingawale describes how (after 32 tries) he and his team created a simple, portable, low-cost device that can test for anemia without breaking the skin.

Myshkin Ingawale is the co-founder of Biosense Technologies, which has built ToucHB, a portable, non-invasive device to test for anemia.

[ted id=1395][en línea] New York (USA):,29 March of 2012 [REF. March of 2012] Available on internet:

The whole picture with one sweep. New syngo DynaCT 360 software from Siemens speeds up rotational angiography

26 03 2012

Siemens Healthcare presents a new feature for Artis zeego, the only interventional imaging system on the market utilizing robotic technology. Thanks to the syngo DynaCT 360 application, an angiography system for the first time can rotate 360 degrees in six seconds to provide CT-like slice images with a field of view of 35 by 25 centimeters. Up to now the C-arm has taken 16 seconds to achieve such extensive soft tissue coverage, as is necessary for abdominal interventions. An exposure time reduced by more than one half brings a number of advantages: it is now unnecessary for the patients to hold their breath for so long during the exposure, and the images are subject to fewer motion artifacts. Furthermore, the physician generally needs to administer less contrast agent. Syngo DynaCT 360 is one of the innovations of Siemens Healthcare’s recently announced Agenda 2013 investment program.

The clinical image shows a 35x25 cm large image of the liver taken with the Syngo DynaCT 360 from Siemens. The hepatic artery and its twigs are made visible with the aid of contrast media.

The clinical image shows a 35×25 cm large image of the liver taken with the Syngo DynaCT 360 from Siemens. The hepatic artery and its twigs are made visible with the aid of contrast media.

The syngo DynaCT 360 software is a further development of syngo DynaCT, a Siemens-developed technology that creates CT-like slice images from the approximately 400 images made during a rotational angiography, and displays them on screen in the angiography suite while the intervention is still in progress. Particularly in the case of unexpected complications during the intervention and also for immediate follow-up, this enables physicians to arrive at a precise diagnosis without needing to transfer the patient to the CT suite.

Compared with syngo DynaCT, syngo DynaCT 360 has a larger field of view: the volume of a patient’s anatomy recorded during a rotation now measures 35 by 25 centimeters. In addition, the new application can record the field of view roughly twice as fast as before, thus reducing motion artifacts on the images. Thanks to the shorter recording time, patients do not need to hold their breath for as long. Additionally the examination requires less contrast agent and patients can be exposed to less radiation.

During therapy, the large field of view offered by syngo DynaCT 360 makes it possible to visualize entire organs, such as the lungs and liver, as well as tumors, including their tumor-supplying vessels. For example, the large field of view is advantageous if the liver is already enlarged, or the patient is adipose. In addition, the high quality of the soft tissue imaging facilitates needle guidance, biopsies or ablations, e.g. by radio frequency or microwave.

Syngo DynaCT 360 runs on Artis zeego, part of Siemens’ Artis-zee family of interventional imaging systems.

Launched by Siemens Healthcare Sector in November 2011, Agenda 2013 is a two-year global initiative to further strengthen the Healthcare Sector’s innovative power and competitiveness.

Specific measures will be implemented in four fields of action: Innovation, Competitiveness, Regional Footprint, and People Development.

A press picture for syngo DynaCT 360 will be available at: [en línea] Munich (GER):, 26 de marzo de 2012 [REF. 06 March of 2012] Available on Internet:

The UAB and Janus developed nanopildoras which release drugs inside cells

22 03 2012

Researchers from the Universitat Autònoma de Barcelona (UAB) they have developed some insoluble and stable nanopildoras that can operate as a new vehicle for the release of proteins with therapeutic activity directly on the inside of the cells. The technology has been licensed to the Janus Developments company, that you have checked the tolerance his administration in vivo.

Las 'nanopíldoras' son un nuevo vehículo para la liberación de proteínas terapéuticas. Imagen: UAB.

The ‘ nanopildoras’ they are a new vehicle for the release of therapeutic proteins. Image: UAB.

A team of researchers from the Universitat Autònoma de Barcelona has developed a new vehicle for the release of proteins with therapeutic activity. This is the so-called “bacterial inclusion bodies”, stable and insoluble nanoparticles that are usually found in recombinant bacteria. Technology, named as ‘ nanopildoras ’, It has been licensed to the company Janus Developments, Headquartered in the Parc Científic de Barcelona, that tested the tolerance of his administration in vivo. The results are published this week in reviews it Advanced Materials.

According to the researchers, Although these "bacterial inclusion bodies" have traditionally been an obstacle in the industrial production of soluble enzymes and patients, they have recently been recognized as containers of large quantities of functional proteins with a direct value in industrial and biomedical applications.

The team of researchers of the UAB biomedicine i Biotechnology Institute (IBB) Antonio Villaverde, in collaboration with the Networked in bioengineering, biomedical research center, Biomaterials and nanomedicine (CIBER-BBN), It has demonstrated the value of these nanoparticles as natural 'nanopildoras' with a great capacity to penetrate inside cells and develop biological activity. "The concept of 'nanopildora' represents a new and promising platform for the administration of drugs in medicine and illustrates the enormous potential", yet to explore, "of microbial materials in medicine", point out those responsible for the project.

Recovery of diseased cells

Researchers, a multidisciplinary study carried out at the UAB led by Dr. Esther Vazquez, they have been packaged four proteins with different therapeutic usefulness, in 'nanopildoras' pilot, bacteria inclusion bodies Escherichia coli. Scientists have been in touch the bacteria with cultures of mammalian cells under conditions similar to those they would be in a real clinical pathology, sick little viable cells, and they have managed to recover its activity.

The multidisciplinary research has involved researchers at the IBB, the Department of genetics and microbiology and cell biology department, Physiology and Immunology of the UAB, CIBER-BBN, Cyber-EHD (Biomedical research center network in the thematic Area of digestive and liver diseases), the Janus Developments company, of the Leibniz University of Hanover (Alemania) and the Helmholtz Centre for Infection ResearchGermanyia).

The use of inclusion bodies as therapeutic agents has been patented by the UAB and CIBER-BBN (the patent code: WO2010131117A1), and licensed to biotechnology company Janus Developments, It currently invests in the development of the product.

Bibliographic reference:

Vázquez, E., Corchero, J. L., Burgess, J. (F)., Seras Franzoso, (J)., Kosoy, A., Bøsser, R., Mendoza, (R)., Martinez-LaineJ, J. M., Fights, Ü., Fernand(E)., E., Ruiz-Avi(L)., L., Garcia-Fruitós, E. and Villaverde, A. (2012), Functional Inclusion Bodies Produced in Bacteria as Naturally Occurring Nanopills for Advanced Cell Therapies. Advisor. Mater.. DOI: 10.1002/ADMA.201104330. [en línea] Madrid (ESP):, 22 de marzo de 2012 [REF. 13 March of 2012] Available on Internet:

Mutations in the gene BRG1 give resistance to hormones in lung cancer

19 03 2012

The 30% non-small cell lung cancer patients have this gene alterations.

Retinoic acid (Vitamin A) and steroids are hormones that are to our bodies that protect from oxidative stress, reduce inflammation and are involved in processes of cell differentiation. One of the features of tumors is that their cells have lost the ability to differentiate, these hormones have useful properties to prevent cancer. Currently, Retinoic acid and steroids are used for the treatment of some types of leukemia.

Vista al microscopio de células de cáncer de pulmón, tratadas con ácido retinoico y corticoides, que tienen BRG1 mutado (rojas) y que tienen BRG1 restituido (verdes). Se observan diferencias morfológicas porque las verdes de diferencian en células pulmon

View under the microscope of lung cancer cells, treated with Retinoic acid and corticosteroids, they have mutated BRG1 (Red) and have restored BRG1 (Green). There are morphological differences because the green of differentiated lung cells

A study led by the research group of Genes and Cancer of the Bellvitge Biomedical Research Institute (IDIBELL) demonstrated that the loss of the gene BRG1 implies a lack of response of cells to these hormones, and therefore the tumor can continue to grow. The results of the study have been published in the magazine EMBO Molecular Medicine.

Gene BRG1

The Group of Genes and Cancer of the IDIBELL led by researcher Montse Sanchez-cespedes discovered a few years ago that gen BRG1, suppressor of tumors, It is inactivated by genetic mutations non small cell lung cancer. "BRG1 protein is part of a complex remodeling of chromatin that regulates the expression of several genes", the researcher explained, "and is related to the differentiation of lung cells", "since it allows the response of cells to certain hormones and vitamins of the environment such as vitamin A or steroids".

When is BRG1 mutated and thus inactive, tumor cells do not respond to the presence of these hormones and continue to grow and expand. For this reason, These types of tumors are refractory to treatment with these substances.

Clinical application

"For the moment", warns Montse Sanchez-cespedes, "we are not able to restore the functionality of a tumor suppressor gene as BRG1 patients". It is therefore, We are still very far from a therapeutic application but the discovery allows us to better understand the biology of tumors. What we do in the immediate future is to find agents that destroy the cells with mutated BRG1 specifically, "following the strategy of synthetic lethal".

In any case, the finding Yes can be useful in the advancement of personalized medicine, already "explains because patients with lung cancer are resistant to these treatments, and could be used to rule out therapies derived from lipid hormones in patients who have mutations in BRG1", not only in lung cancer, but also in breast and prostate cancer, "among others".

The article reference

Romero, O.*, Setién, F.*, John S., Gimenez-Xavier P.*, Gomez-Lopez G., Condom E.*, Villanueva A.*, G Hager. and Sanchez-cespedes regimen. The tumor supressor and chromatin remodeling factor BRG1 antagonizes Myc Activity and promotes cell diferentiation in human cancer. EMBO Molecular Medicine. DOI 10.1002/emmm.201200236. [en línea] Barcelona (ESP):, 19 de marzo de 2012 [REF. 15 March of 2012] Available on Internet:

They save the life to a fetus with an endoscopy to Unclog a bronchus

15 03 2012

Specialists of the Hospital Clínic and Sant Joan de Déu have practiced surgery pioneer in the world to Unclog a clogged bronchus of a fetus with an endoscopy of 26 weeks, an operation that saved his life.

“Thanks to ultrasound could be detected the problem in time; If I had not intervened, the girl would be dead”, has featured today in a press conference Dr. Julio Moreno, the catalan Sant Joan de Déu hospital neonatologist.

After the operation, the pregnancy had a normal evolution and, to the 38 weeks and with 2,5 kg, was born a girl that currently has 16 months and makes a normal life.

It is the first time in the world involving a fetus of a bronchial atresia right (serious obstruction of the bronchial tubes) through a tiny endoscope, of 3 mm, by the trachea.

Anatomía del árbol bronquial

Anatomy of the bronchial tree

After entering the appliance through the mouth of the fetus, specialists from the Clinic of Barcelona and Sant Joan de Déu observed the obstruction and drilled it with a laser, in a manner that reconectaron the bronchi and thus deflated lung to regain its normal size.

Bronchial atresia at fetal stage had described above, but in all cases not be had been able to intervene and the fetus had died before birth or shortly after delivery.

The operation presented today, was it carried out a year and a half ago, was short, half hour, but very delicate, because that was practiced in a fetus of 800 grams with such tissues as a role of smoking and a few millimeters of the heart.

In the case presented today, one of the main bronchi that connect the trachea lung was not well formed and lacked a portion, What did the lung stayed isolated and their secretions cumulate, This body swelling and causing heart failure.

With words of gratitude to the doctors, the mother of the baby, Monica Colomina, of 33 years, It has reported today the moment in which proposed you to intervene it: “It was the only option, We tested or interrupted pregnancy”.

As explained by his mother, the girl, that is called Alaitz (that means joy in Basque) ago “a completely normal life and is happy and happy”.

The only intervention that has had to undergo Alaitz thirteen days of birth was a surgical operation to remove two of the three lobes of the right lung, damaged by bronchial obstruction.

According to the Montserrat Dr. CASTAÑÓN, Sant Joan de Déu Pediatric surgeon, having lost two lobes of a lung does not affect the quality of life of Alaitz in any aspect.

The intervention, designed entirely in Barcelona by specialists of the Clinic and Sant Joan de Déu, offers an option to save the life of a congenital abnormality such as bronchial atresia which affects one of every 10.000 fetuses.

The Chief of the service of fetal medicine of the Clínic Hospital, Eduard Gratacós, It pointed out that new treatments as presented today show that Barcelona is reference in medical innovation and that Catalonia has a system of public health “terrific”.

The Hospital de Sant Joan de Déu and the Clinic collaborate on various projects and are part of the “Health University of Barcelona Campus” (HUBc), an Alliance or ‘ hub’ which encompasses to 30 the training entities, research and knowledge transfer in the field of the health sciences.

In fetal surgery, the Clinic and Sant Joan de Déu give solution to more of 200 cases of pathologies, constituting one of the five centers in the world with more volume of interventions in this area. [en línea] Madrid (ESP):, 15 de marzo de 2012 [REF. 13 March of 2012] Available on Internet:

Epidemiology to analyze the conflicting messages in the field of health

12 03 2012

A mathematician at the research and primary care of the HUNSC unit analyzes the conflicting messages in the field of health from the perspective of epidemiology.

Armando Aguirre, matemático del Hospital de La Candelaria, en los laboratorios de la Unidad de Investigación.

Armando Aguirre, mathematician of the Hospital de La Candelaria, in the laboratories of the research unit.


Armando Aguirre Jaime explains in his work "Epidemiometria. A trip from the roots", why this discipline is currently in crisis by making a journey through the history of epidemiology and examines the contradictory messages that are released to the society in the field of public health.

Epidemiology is one of the pillars on which rests the knowledge of medicine and health. Thanks to the application of this discipline in the health sector, Today you can learn a little more about the behavior of disease in specific surroundings and a population. Applied since ancient times, It sought to discover the origin of the disease either guiding research into the causes originating them.

Precisely on the history of epidemiology and its current situation, Armando Aguirre, mathematician in the unit of research of Hospital Universitario Ntra. SRA. Candelaria and primary care, attached to the Ministry of health of the Government of Canary Islands, He has presented the work "Epidemiometria. A trip from the roots", with special focus on the moment in which mathematics converge with this matter, for already more than 400 years.

The Book, published by Bubok Publishing SL, It is a trial that collects along of 361 pages the history of a discipline that is in crisis as explained by its author in the 21st century, which is reflected in the numerous conflicting and confusing messages that society has received in recent years in the field of health.

An example is that "years ago, epidemiologists said that eating oily fish was harmful to health and eventually confirmed otherwise. This confusion in some health information is perceived by society and by the own doctors, and it is the result of the crisis today is experiencing this scientific discipline", It confirms the Hospital Universitario Ntra methodologist. SRA. Candelaria, Armando Aguirre. This essay, aimed at researchers and healthcare professionals working in this field, It contains several proposals for the author that this situation of uncertainty is at issue, In addition to tracing the pathways of a desirable future for epidemiology.

Mathematics and health

The application of mathematics to the field of health has helped researchers identify risk factors and establish methods for study of a more accurate and clear way the behavior of the disease and its prevention. Is for this reason that today, the role of the mathematician in the centres of knowledge creation and management is essential. His work is the methodological support requiring all medical research team, advising and designing the most appropriate procedures in order to raise the maximum scientific rigor of studies.

Biography of the author

Armando Aguirre Jaime (La Habana, 1950), mathematical training, He has dedicated his professional activity to the application of this science to the field of medical and health research. This is his sixth book on the subject and, In addition, has to his credit more than 200 scientific articles in medical journals.

At present Nuestra Señora Candelaria is his work as a methodologist in the research unit of the University Hospital (HUNSC) and primary care of Tenerife, activity sharing tasks as a teacher at the national school of health of Madrid, the school of health services and social of the Canary Islands (ESSSCAN), the unit teaching of Medicine of family of the University Hospital of the Canary Islands (HUC), the College of nursing of Tenerife, the National University of distance education (UNED) or the teaching unit of matrons of the HUNSC, among others. [en línea] Cadiz (ESP):, 12 March of 2012 [REF. 21 de febrero de 2012] Available on Internet:

Immortal worms defy ageing

8 03 2012

Researchers from The University of Nottingham have demonstrated how a species of flatworm overcomes the ageing process to be potentially immortal.

The discovery, published in the Proceedings of the National Academy of Sciences, is part of a project funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and Medical Research Council (MRC) and may shed light on the possibilities of alleviating ageing and age-related characteristics in human cells.

Planarian worms have amazed scientists with their apparently limitless ability to regenerate. Researchers have been studying their ability to replace aged or damaged tissues and cells in a bid to understand the mechanisms underlying their longevity.

Dr Aziz Aboobakerfrom the University’s School of Biology, said: “We’ve been studying two types of planarian worms; those that reproduce sexually, like us, and those that reproduce asexually, simply dividing in two. Both appear to regenerate indefinitely by growing new muscles, skin, guts and even entire brains over and over again. "Usually when stem cells divide - to heal wounds", or during reproduction or for growth — they start to show signs of ageing. This means that the stem cells are no longer able to divide and so become less able to replace exhausted specialised cells in the tissues of our bodies. Our ageing skin is perhaps the most visible example of this effect. Planarian worms and their stem cells are somehow able to avoid the ageing process and to keep their cells dividing.”

One of the events associated with ageing cells is related to telomere length. In order to grow and function normally, cells in our bodies must keep dividing to replace cells that are worn out or damaged. During this division process, copies of the genetic material must pass on to the next generation of cells. The genetic information inside cells is arranged in twisted strands of DNA called chromosomes. At the end of these strands is a protective ‘cap’ called a telomere. Telomeres have been likened to the protective end of a shoelace which stops strands from fraying or sticking to other strands.

Theoretical immortality

Each time a cell divides the protective telomere ‘cap’ gets shorter. When they get too short, the cell loses its ability to renew and divide. In an immortal animal we would therefore expect cells to be able to maintain telomere length indefinitely so that they can continue to replicate. Dr Aboobaker predicted that planarian worms actively maintain the ends of their chromosomes in adult stem cells, leading to theoretical immortality.

Dr Thomas Tan made some exciting discoveries for this paper as part of his PhD. He performed a series of challenging experiments to explain the worm’s immortality. In collaboration with the rest of the team, he also went some way to understanding the clever molecular trick that enabled cells to go on dividing indefinitely without suffering from shortened chromosome ends.

Previous work, leading to the award of the 2009 Nobel Prize for Physiology or Medicine, had shown that telomeres could be maintained by the activity of an enzyme called telomerase. In most sexually reproducing organisms the enzyme is most active only during early development. So as we age, telomeres start to reduce in length.

This project identified a possible planarian version of the gene coding for this enzyme and turned down its activity. This resulted in reduced telomere length and proved it was the right gene. They were then able to confidently measure its activity and resulting telomere length and found that asexual worms dramatically increase the activity of this gene when they regenerate, allowing stem cells to maintain their telomeres as they divide to replace missing tissues.

Clearer proof

Dr Tan pointed out the importance of the interdisciplinary expertise: “It was serendipitous to be sandwiched between Professor Edward Louis’s yeast genetics lab and the Children’s Brain Tumour Research Centre, both University of Nottingham research centres with expertise in telomere biology. Aziz and Ed kept demanding clearer proof and I feel we have been able to give a very satisfying answer.”

However, what puzzled the team is that sexually reproducing planarian worms do not appear to maintain telomere length in the same way. The difference they observed between asexual and sexual animals was surprising, given that they both appear to have an indefinite regenerative capacity. The team believe that sexually reproductive worms will eventually show effects of telomere shortening, or that they are able to use another mechanism to maintain telomeres that would not involve the telomerase enzyme.

Dr Aboobaker concluded: “Asexual planarian worms demonstrate the potential to maintain telomere length during regeneration. Our data satisfy one of the predictions about what it would take for an animal to be potentially immortal and that it is possible for this scenario to evolve. The next goals for us are to understand the mechanisms in more detail and to understand more about how you evolve an immortal animal.”

Professor Douglas Kell, BBSRC Chief Executive, said: “This exciting research contributes significantly to our fundamental understanding of some of the processes involved in ageing, and builds strong foundations for improving health and potentially longevity in other organisms, including humans.”

YouTube Preview Image

Immortal worms defy ageing: [en línea] Nottingham (UK):, 08 March of 2012 [REF. 27 de febrero de 2012] Available on Internet:
y Neverending DNA and Immortal Worms: [en línea] Nottingham (UK):, 08 March of 2012 [REF. 27 de febrero de 2012] Available on Internet:

Dr HERRERO: New actors implanted the tele-medicine

5 03 2012

Javier Herrero Jover, MD, PhD

President of Alma IT Systems

Some time ago we presentíamos ICT change in an important way the health but it was not until the big telecommunications companies have emerged as new actors, that this change not be has failed to materialize. This change brings first both times and resource optimization, a generalization or globalization, very current Word and customization of health.  The reason is very simple, We could not implement global technology solutions at a distance if we did not have a powerful data transmission, effective and safe.

Telemedicine, Tele, Tele-cirugia, Tele-Diagnostico, Tele-mentoring, they were very attractive concepts, but without the guarantee of its transmission, in something as important as the health, its implementation was unthinkable. We had the concept, the demand, needs, even some of the technology, and now, Thanks to these new actors, We have the channel, so for your safety, and the volume of transmission.

He spoke of optimization, generalization and customization. Let's start with the first concept, the lowering, tremendously important in the times that we live and think to understand it, in a banal health fact and other vital. In the first, think of a patient with a skin lesion that goes to your primary care physician, Once valued the lesion, You must refer to the specialist in dermatology which will diagnose it and treat. Someone, an administrative, recorded two quotes, There are two doctors involved and the patient has required two displacements and two labour permits. The implementation of systems of tele-diagnostico in health centres, They allow you to refer your medical history and the image of the lesion to the specialist, who directly appreciates and recommends a course of treatment to immediately, at that time to pose a simple and suitable performance criterion.

On the opposite side of gravity, think of a brain stroke a patient living in a peripheral population, where emergency professional, should refer the patient to a specialist Center where it was valued and treated if necessary. Displacement, family disorder and the Centre of reference overload can be avoided with systems of tele-diagnostico where the patient is valued in the referral hospital unless it has been mobilized peripheral hospital.   If the therapeutic indication is medical, You will be treated in situ without having to move it. Investment and ICT introduction shouldn't be seen as an expense not even as an investment since its implementation rapidly causes lower.

Why I speak of generalization?? The introduction of ICTs in the case which concerns us, telemedicine offers solutions that only yesterday were at the service of patients close to centres of excellence and today already can offer to the rest of the community. We must recognize that a patient away from highly specialized centres, He received over deficit attention since in such hospitals were the best specialists nor such hospitals were equipped with the latest. Today, Thanks to the guarantee of data transmission that allow these telecommunications companies and the introduction of the TELE, such patients on the periphery, they may have a similar and homogeneous treatment. For all these reasons, the introduction of ICTs, causes the change of paradigm, today all patients can benefit from all the advances.

At last, If you think those complex diseases, or tortuous developments of a given pathology, the use of the TELE, quickly enable a professional consult or refer the explorations to the sub-especialista and this requires the knowledge of the experience, meet the cases that occur outside of their environment.

In a short time, as happens with ICT in our daily life,the phone, car GPS, for example, We think as we could attend to patients without the technologies.

La hora iDoctor en el Mobile World Congress

1 03 2012

One of the central themes of the Mobile World Congress 2012 in Barcelona is the of Mobile Health (mHealth): 'Mobile health'. New technologies have prompted a series of innovations in the field of research and health services, both for professionals, care centres and patients. In addition to all the possibilities that are opened on computers, Web and applications, These developments have an additional ingredient of importance: the international impact is leading, in several cases, greater access to resources in communities in low-income countries.

The MWC has scheduled conferences, seminars, a showroom with six companies of the branch and a session 'in action' in the Hospital del Mar, with experts from Catalonia, Germany and Greece. The sessions have recognized participants, among them the doctor Josep Spades of the Hospital de Sant Pau and Christopher Wasden PWC. Among the items on the agenda: a review of what has been learned so far in the field in question, How to "build confidence", "creating demand", sustainability of the business and the prospects for growth in emerging markets.

Currently, several companies are working to offer more services designed to operate online and in the form of applications of general well-being, Bless you, medicine and physical fitness that represent major changes in standard practices for Diagnostics, treatments, dissemination of information on drugs and relationships between medical workers and patients. The month of January, the Silicon Valley investor Vinod Khosia published a analysis of how the so-called "Doctor algorithm" you can change the "literal and metaphorical face of health care". RIP Empson, on Techcrunch, makes a tour of the scene in This article published on 16 January.

A I am a student October 2010 Pew Research pointed out already a 17% people who regularly used their mobile phones to search for medical and health information in general. It is estimated that more than 40 millions of these topics applications were downloaded in total last year. However, forecasts of growth in this field to 2015-16 They vary between the market analysts, with profits that could range between the $400 and $700 millions of dollars. Empson analyzes these possible scenarios and rightly points out that one of the outstanding issues is to define what is meant by mobile health, 'apps' health, e-medicine and other associated terms that may or not be cobijados under mHealth.

The other aspect to consider is that the profusion of web services and apps can cause confusion: What are reliable??, what they have an approval process followed by medical and governmental authorities??, be imposed regulations to mobile technology resources used by the health personnel??. "Which initiatives will be allowed to grow... perhaps the most innovative apps and increased aid they will never see the daylight?"?"Empson wondered".

For those who are interested, It is recalled that in the CES fair last January, the Foundation X Prize launched its 'tricorder' contest: a mobile platform that can accurately diagnose a group of 15 diseases among 30 people during 3 days.

Recommended reading: the document 2011 about new horizons in health and technology (eHealth) of the World Health Organization, with chapters dedicated to topics such as outstanding initiatives, informed decisions systems, Mobile telemedicine, barriers in the development of new resources and detailed analysis by groups of countries members of the Organization and according to World Bank classifications. The pass Conference who on the subject held in Malaga in November 2011 and This year the dates are may 27-30 in Vancouver, Canada.

The sessions at the WMC in Barcelona are a good preparation for the upcoming summits Mobile Health Summit, in Cape Town of the 29 from May to June 1, and HealthSummit on technology, business, research and policy to be carried out of the 3 to the 5 December in Washington. For those who want to take a look at some popular applications: Pill reminder, recordario pills to take, from for the Webby site 2011), MyBasis for cardiac monitoring, Philips' Vital Signs Camera measuring heart rate and respiration, Skin Scan, which measures potential risk of skin cancer. And if you don't have public transport to get to the venue of the Congress, the recommendation is to walk (or run), in general it is healthy, y luego analizar los datos del ejercicio en una plataforma especializada como, for example, RunKeeper. [en línea] Barcelona (ESP):, 01 March of 2012 [REF. 21 de febrero de 2012] Available on Internet: